Literature DB >> 29921615

Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Naoki Oishi1,2, Garry S Brody3, Rhett P Ketterling1, David S Viswanatha1, Rong He1, Surendra Dasari4, Ming Mai1, Hailey K Benson1, Christopher A Sattler1, Rebecca L Boddicker1, Ellen D McPhail1, N Nora Bennani5, Christin A Harless6, Kuldeep Singh6, Mark W Clemens7, L Jeffrey Medeiros8, Roberto N Miranda8, Andrew L Feldman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29921615      PMCID： PMC6073323          DOI： 10.1182/blood-2017-12-821868

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  26 in total

1.  Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Authors:  Rebecca L King; Linda N Dao; Ellen D McPhail; Elaine S Jaffe; Jonathan Said; Steven H Swerdlow; Christopher A Sattler; Rhett P Ketterling; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; Sarah E Gibson; Sarah L Ondrejka; Alina Nicolae; William R Macon; Surendra Dasari; Edgardo Parrilla Castellar; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

4.  Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.

Authors:  Arianna Di Napoli; Preti Jain; Enrico Duranti; Elizabeth Margolskee; Walter Arancio; Fabio Facchetti; Bachir Alobeid; Fabio Santanelli di Pompeo; Mahesh Mansukhani; Govind Bhagat
Journal:  Br J Haematol       Date:  2016-11-10       Impact factor: 6.998

5.  Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Authors:  Piers Blombery; Ella R Thompson; Kate Jones; Gisela Mir Arnau; Stephen Lade; John F Markham; Jason Li; Anand Deva; Ricky W Johnstone; Amit Khot; H Miles Prince; David Westerman
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

Review 6.  Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases.

Authors:  Garry S Brody; Dennis Deapen; Clive R Taylor; Lauren Pinter-Brown; Sarah Rose House-Lightner; James S Andersen; Grant Carlson; Melissa G Lechner; Alan L Epstein
Journal:  Plast Reconstr Surg       Date:  2015-03       Impact factor: 4.730

7.  Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.

Authors:  Joseph D Khoury; L Jeffrey Medeiros; George Z Rassidakis; Marwan A Yared; Panagiota Tsioli; Vasiliki Leventaki; Annette Schmitt-Graeff; Marco Herling; Hesham M Amin; Raymond Lai
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

8.  Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder.

Authors:  Anja C Roden; William R Macon; Gary L Keeney; Jeffrey L Myers; Andrew L Feldman; Ahmet Dogan
Journal:  Mod Pathol       Date:  2008-01-25       Impact factor: 7.842

9.  Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.

Authors:  Maria C Ferrufino-Schmidt; L Jeffrey Medeiros; Hui Liu; Mark W Clemens; Kelly K Hunt; Camille Laurent; Julian Lofts; Mitual B Amin; Siaw Ming Chai; Angela Morine; Arianna Di Napoli; Ahmet Dogan; Vinita Parkash; Govind Bhagat; Denise Tritz; Andres E Quesada; Sergio Pina-Oviedo; Qinlong Hu; Francisco J Garcia-Gomez; Juan Jose Borrero; Pedro Horna; Beenu Thakral; Marina Narbaitz; R Condon Hughes; Li-Jun Yang; Jonathan R Fromm; David Wu; Da Zhang; Aliyah R Sohani; John Hunt; Indira U Vadlamani; Elizabeth A Morgan; Judith A Ferry; Reka Szigeti; Juan C Tardio; Rosario Granados; Susanne Dertinger; Felix A Offner; Andreas Pircher; Jeff Hosry; Ken H Young; Roberto N Miranda
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

10.  Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.

Authors:  G Hu; S Dasari; Y W Asmann; P T Greipp; R A Knudson; H K Benson; Y Li; B W Eckloff; J Jen; B K Link; L Jiang; J S Sidhu; L E Wellik; T E Witzig; N N Bennani; J R Cerhan; R L Boddicker; A L Feldman
Journal:  Leukemia       Date:  2017-10-13       Impact factor: 11.528
View more
  27 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Authors:  Camille Laurent; Alina Nicolae; Cécile Laurent; Fabien Le Bras; Corinne Haioun; Virginie Fataccioli; Nadia Amara; José Adélaïde; Arnaud Guille; Jean-Marc Schiano; Bruno Tesson; Alexandra Traverse-Glehen; Marie-Pierre Chenard; Lénaïg Mescam; Anne Moreau; Catherine Chassagne-Clement; Joan Somja; Frédéric Escudié; Marc André; Nadine Martin; Laetitia Lacroix; François Lemonnier; Anne-Sophie Hamy; Fabien Reyal; Marie Bannier; Lucie Oberic; Nais Prade; François-Xavier Frénois; Asma Beldi-Ferchiou; Marie-Helene Delfau-Larue; Reda Bouabdallah; Daniel Birnbaum; Pierre Brousset; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

Review 3.  Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Mark W Clemens; Ryan C DeCoster; Berry Fairchild; Alexander A Bessonov; Fabio Santanelli di Pompeo
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

Review 4.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 5.  Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  P Rastogi; A K Deva; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

6.  Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Authors:  Elaine S Jaffe; Binita S Ashar; Mark W Clemens; Andrew L Feldman; Philippe Gaulard; Roberto N Miranda; Aliyah R Sohani; Timothy Stenzel; Sung W Yoon
Journal:  J Clin Oncol       Date:  2020-02-11       Impact factor: 44.544

7.  How I treat breast implant-associated anaplastic large cell lymphoma.

Authors:  Neha Mehta-Shah; Mark W Clemens; Steven M Horwitz
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

8.  Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.

Authors:  Andrés E Quesada; Yanming Zhang; Ryan Ptashkin; Caleb Ho; Steven Horwitz; Ryma Benayed; Ahmet Dogan; Maria E Arcila
Journal:  Breast J       Date:  2021-02-18       Impact factor: 2.431

Review 9.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

Review 10.  Breast implant-associated anaplastic large cell lymphoma: a review.

Authors:  Andrés E Quesada; L Jeffrey Medeiros; Mark W Clemens; Maria C Ferrufino-Schmidt; Sergio Pina-Oviedo; Roberto N Miranda
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.